Literature DB >> 18264932

The MAURO study: multiple intervention and audit in renal diseases to optimize care.

Carmine Zoccali1, Daniela Leonardis, Giuseppe Enia, Maurizio Postorino, Francesca Mallamaci.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18264932

Source DB:  PubMed          Journal:  J Nephrol        ISSN： 1121-8428            Impact factor:   3.902


× No keyword cloud information.
  4 in total

1.  Competitive interaction between fibroblast growth factor 23 and asymmetric dimethylarginine in patients with CKD.

Authors:  Giovanni Tripepi; Barbara Kollerits; Daniela Leonardis; Mahamut Ilker Yilmaz; Maurizio Postorino; Danilo Fliser; Francesca Mallamaci; Florian Kronenberg; Carmine Zoccali
Journal:  J Am Soc Nephrol       Date:  2014-08-22       Impact factor: 10.121

2.  Epidemiology of hyperkalemia in CKD patients under nephrological care: a longitudinal study.

Authors:  Vincenzo Panuccio; Daniela Leonardis; Rocco Tripepi; Maria Carmela Versace; Claudia Torino; Giovanni Tripepi; Graziella D'Arrigo; Francesca Mallamaci; Carmine Zoccali
Journal:  Intern Emerg Med       Date:  2021-02-11       Impact factor: 3.397

3.  High estimated pulmonary artery systolic pressure predicts adverse cardiovascular outcomes in stage 2-4 chronic kidney disease.

Authors:  Davide Bolignano; Simone Lennartz; Daniela Leonardis; Graziella D'Arrigo; Rocco Tripepi; Insa E Emrich; Francesca Mallamaci; Danilo Fliser; Gunnar Heine; Carmine Zoccali
Journal:  Kidney Int       Date:  2015-02-18       Impact factor: 10.612

4.  Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD.

Authors:  Belinda Spoto; Francesco Mattace-Raso; Eric Sijbrands; Daniela Leonardis; Alessandra Testa; Anna Pisano; Patrizia Pizzini; Sebastiano Cutrupi; Rosa M Parlongo; Graziella D'Arrigo; Giovanni Tripepi; Francesca Mallamaci; Carmine Zoccali
Journal:  Clin J Am Soc Nephrol       Date:  2014-12-09       Impact factor: 8.237
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.